Can anyone answer these 3 basic question:-
(1) How does a private patient afford to pay $25,000 US dollars for one single dose of the Oncosil device?
(2) Will a health insurance fund provide insurance for the Oncosil device in Europe following the CE Mark approval?
(3) Will the government health authority such as the NHS in the UK provide financial reimbursement for the Oncosil device?
Appreciate any constructive thoughts on these questions.
- Forums
- ASX - By Stock
- OSL
- Ann: OncoSil receives Swiss regulatory approval
OSL
oncosil medical ltd
Add to My Watchlist
2.00%
!
$1.02

Ann: OncoSil receives Swiss regulatory approval, page-30
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.02 |
Change
0.020(2.00%) |
Mkt cap ! $14.50M |
Open | High | Low | Value | Volume |
$1.00 | $1.04 | 99.5¢ | $44.55K | 44.45K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 192 | $1.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.04 | 6234 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 283 | 1.025 |
1 | 550 | 1.020 |
3 | 8993 | 1.000 |
1 | 3000 | 0.990 |
1 | 1000 | 0.975 |
Price($) | Vol. | No. |
---|---|---|
1.020 | 353 | 1 |
1.050 | 25000 | 1 |
1.075 | 1879 | 1 |
1.090 | 375 | 1 |
1.120 | 6234 | 1 |
Last trade - 15.48pm 25/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online